Form D · Biotechnology
Finch Therapeutics Group, Inc.
Somerville, MA · CIK 0001733257
Offering snapshot reported Sep 23, 2020 · SEC filing
- Reported sold
- $90M Offering amount: $90M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 2, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$88,489,483 → $90,000,000
- Reported investors42 → 43
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2020 | Amendment | $90,000,000 | $1,510,517vs Sep 17, 2020 | 43 | SEC filing |
| Sep 17, 2020 | Initial | $88,489,483 | No comparison | 42 | SEC filing |
| Jul 19, 2019 | Amendment | $53,465,316 | $30,465,320vs May 20, 2019 | 22 | SEC filing |
| May 20, 2019 | Initial | $22,999,996 | No comparison | 16 | SEC filing |
| Mar 5, 2018 | Initial | $36,399,996 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-375815
Source: Form D, filed Sep 23, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Burgess | Executive |
| Christopher Cosmides | Director |
| Benjamin Enerson | Executive |
| Domenic Ferrante | Director |
| Alan Gross | Director |
| Zain Kassam | Executive |
| Chris Lange | Director |
| Andrew Mulderry | Director |
| Andrew Noh | Executive |
| Greg Perry | Executive |
| R. J. Price | Director |
| Jeffery A. Smisek | Director |
| Mark Smith | Director, Executive |
| Ulrich Thienel | Executive |
| Jo Viney | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Inner Belt Road
Somerville, MA, 02143
Somerville, MA, 02143